Gastroenterology

Health economic study highlights new approach to colorectal cancer screening

Published in Cancer Weekly, May 21st, 2002

A new screening test for colorectal cancer could reduce the cost of screening programs for the disease, according to a new health economic study.

ColorectAlert, developed by IMI International Medical Innovations, Inc., detects a cancer-associated sugar in a mucus sample. The health economic study comparing ColorectAlert with the current standard test - fecal occult blood test (FOBT) - was presented at the Canadian Association for Population Therapeutics meeting in Toronto and the abstract is published in the current issue of the Canadian Journal of Clinical Pharmacology.

The study modeled a theoretical screening program for a population of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-05-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry